Transarterial chemoembolization combined with lenvatinib plus tislelizumab for unresectable hepatocellular carcinoma: a multicenter cohort studyYushan Zhao, Yi Chen, YaoQing Xue et al.|Frontiers in Immunology|2024Cited by 7